Copyright © 2000 by the European Society of Cardiology.
Editorial
The EMIP Project
Department of Cardiovascular Research, Istituto Mario Negri Milan, Italy
References
- Eur Heart J. 2000;21:15371546
[Abstract/Free Full Text] - Boissel, JP, EMIP-FR, a placebo controlled study of trimetazidine in the initial treatment of acute myocardial infarction, 1996
- Reimer KA, Califf RM. Good news for experimental concept but bad news for clinically effective therapy. Circulation. 1999;99:198200
[Free Full Text] - Volpi A, Maggioni A, Franzosi MG, Pampallona S, Mauri F, Tognoni G. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med. 1987;317:257261[Abstract]
This article has been cited by other articles:
![]() |
H. Szwed Comments on EMIP-FR study's editorial Eur. Heart J., August 1, 2001; 22(15): 1359 - 1359. [Abstract] [PDF] |
||||
![]() |
M. Marzilli and M. Mariani About EMIP-FR and reperfusion damage in AMI: a comment to the comment Eur. Heart J., June 1, 2001; 22(11): 973 - 975. [PDF] |
||||
![]() |
A. Grynberg The EMIP-FR Study: the evolution of scientific background as a non-controlled parameter Eur. Heart J., June 1, 2001; 22(11): 975 - 977. [PDF] |
||||
![]() |
J. Soler-Soler and D. Garcia-Dorado Trimetazidine and reperfusion injury Eur. Heart J., June 1, 2001; 22(11): 975 - 975. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
